share_log

Insiders At Axogen Sold US$639k In Stock, Alluding To Potential Weakness

Insiders At Axogen Sold US$639k In Stock, Alluding To Potential Weakness

AXOGEN內部人士出售63.9萬美元股票,可能意味着薄弱性。
Simply Wall St ·  11/09 22:35

Axogen, Inc. (NASDAQ:AXGN) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.

axogen股東可能理由 擔憂許多內部人士在過去一年裏出售了他們的股份。 在評估內部交易時,了解內部人士是否在買入通常更有幫助,因爲內部人士的賣出可能有各種解釋。 然而,如果有幾個內部人士在特定時間段內出售股票,股東應該深入了解。

While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

儘管在長期投資中內部交易並不是最重要的事情,但從邏輯上講,您應該關注內部人員是否買入或出售股票。

Axogen Insider Transactions Over The Last Year

過去一年的axogen內部交易

In the last twelve months, the biggest single sale by an insider was when the insider, Michael Donovan, sold US$320k worth of shares at a price of US$8.81 per share. That means that an insider was selling shares at slightly below the current price (US$12.66). When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. We note that the biggest single sale was 50% of Michael Donovan's holding.

過去十二個月內部人員最大的單次出售是當內部人員邁克爾·多諾萬以每股8.81美元的價格出售32萬美元的股份。 這意味着內部人員以略低於當前價格(12.66美元)出售股份。 當內部人員以低於當前價格出售時,這表明他們認爲較低的價格是合理的。 這讓我們想知道他們對(更高的)最近評估的看法。 雖然內部人員的賣出不是一個積極的跡象,但我們不能確定這是否意味着內部人士認爲股票已經完全價值,因此這只是一個淡弱的跡象。 我們注意到最大的單筆交易佔邁克爾·多諾萬持股的50%。

Insiders in Axogen didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

在過去一年裏,axogen的內部人員沒有購買任何股份。 您可以看到過去12個月內部交易的可視化描述(按公司和個人)。 如果您想知道誰以多少價格何時出售,請在下方的圖表上單擊!

big
NasdaqCM:AXGN Insider Trading Volume November 9th 2024
納斯達克CM:axogen內部交易量2024年11月9日

I will like Axogen better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

如果我看到一些大額內部買入,我會更喜歡axogen。在等待的時候,可以查看這份免費的被低估和小盤股列表,其中有相當數量的最近內部買入。

Insider Ownership

內部人員持股情況

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 4.9% of Axogen shares, worth about US$27m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

對於一位普通股東來說,值得檢查公司內部持有的股份數量。通常,內部持股比例越高,內部人員越有可能受到激勵,長期發展公司。內部人員擁有axogen股份的4.9%,價值約2700萬美元。我們確實在其他地方看到過更高水平的內部持股,但這些持股足以表明內部人員與其他股東之間的契合。

So What Does This Data Suggest About Axogen Insiders?

那麼這些數據對axogen內部人員有何啓示?

The fact that there have been no Axogen insider transactions recently certainly doesn't bother us. We don't take much encouragement from the transactions by Axogen insiders. But we do like the fact that insiders own a fair chunk of the company. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted 1 warning sign for Axogen you should know about.

最近沒有axogen內部交易這個事實並不會讓我們感到困擾。我們並不會從axogen內部人員的交易中得到太多鼓勵。但我們確實喜歡內部人員擁有公司相當大份額的事實。雖然了解內部人員持股和交易情況很重要,但在做出任何投資決策之前,我們會確保考慮到股票面臨什麼風險。每家公司都存在風險,我們發現了axogen的1個警示信號,您應該知曉。

But note: Axogen may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意:axogen可能不是最好的股票買入選擇。所以來看一下這份免費的有高roe和低債務的有趣公司列表。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論